Margarita de la Llera-Moya.

Amit V. Khera, M irritable bowel syndrome .D., Marina Cuchel, M.D., Ph.D., Margarita de la Llera-Moya, Ph.D., Amrith Rodrigues, M.S., Megan F. Burke, B.A., Kashif Jafri, B.A., Benjamin C. French, Ph.D., Julie A. Phillips, Ph.D., Megan L. Mucksavage, M.Sc., Robert L. Wilensky, M.D., Emile R. Mohler, M.D., George H. Rothblat, Ph.D., and Daniel J. Rader, M.D.: Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis A robust inverse association between the degree of high-density lipoprotein cholesterol and the chance of cardiovascular disease has fostered intensive analysis wanting to target HDL rate of metabolism for therapeutic gain.1,2 However, some findings have called into issue the hypothesis that pharmacologic boosts in HDL cholesterol amounts are necessarily beneficial.

$10M NIH grant to reduce coronary disease risk among Latinos in East Los Angeles $10 million NIH grant will create unique partnership between UCLA, USCThe UCLA School of Public Health today announced a $10 million grant from the National Institutes of Health to fund a Center for Population Health and Health Disparities in partnership with the University of Southern California, the LA County Department of Public Health and several community collaborators. The purpose of the center is to reduce coronary disease risk among Latinos in East LA, where 96 % of the populace is of Central or Mexican American ancestry.